Dr. Johann Craus, Obstetrician & Gynaecologist with special interest in pregnancy complicated with Diabetes Mellitus, will be leading this module as part of the The International Masterclass in Diabetes Management. Learning Objectives Diagnosis of GDM is dependent on which diagnostic criteria is used. IADPSG criteria…

Dr. David Coppini, Consultant Diabetologist & Endocrinologist, will be leading this module which will address another important complication of Diabetes Mellitus: diabetic neuropathy. The enigma of neural pain in diabetic individuals , its diagnosis and management will be discussed in detail.

  Foot problems is a feared complication amongst diabetic patients, hence prevention is key in the management of diabetes.

Professor Stephen Fava, Consultant Diabetologist & Endocrinologist, who heads the Diabetes & Endocrine Unit at Mater Dei Hospital, will be discussing risk factor modification in Type 2 Diabetes.

This session will provide an overview regarding when and how to inititiate and intensify insulin treatment in type 2 diabetes, the different insulin formulations available, the barriers to insulin therapy, how these best be overcome these and insight into issues in special populations.

Dr. Sandro Vella, Consultant Endocrinologist & Diabetologist at Mater Dei Hospital, Malta, who will be speaking about the latest 2021 guidelines on management of type 2 diabetes.

Managing overweight and obese patients is a challenge each doctor will surely encounter at any point in his practice. Dr. Rachel Agius, Consultant Diabetologist, Endocrinologist, General Physician and Clinical Lead in Bariatric Medicine at Mater Dei Hospital Malta, provides us with the most updated knowledge…

Insulin, which is the mainstay treatment for type 1 diabetes, has been viewed for many years as a secondary care specialised treatment. As the role of primary care physicians gains more importance in the holistic management of patients, it is vital that these same physicians…

This CME30 session encompasses a discussion and exploration of the main themes around pre-diabetes focusing on diagnosis, screening for DMT2/pre-diabetes and interventions in pre-diabetes. A few landmark studies are discussed. The ADA guidelines on the subject are discussed and explained.

Prof. Stephen Fava, Consultant Diabetologist & Endocrinologist, and Head of the Diabetes and Endocrine Unit at Mater Dei Hospital, discusses the use and effectiveness of novel drugs in the reduction of cardiovascular burden in diabetes. This discussion will follow the presentation on reduction of modifiable…

The guest speaker of this module is Prof. Stephen Fava, who is a Consultant Diabetologist & Endocrinologist and heads the Endocrinology Department at Mater Dei Hospital.